ARCHIVES

RAS Mutations Can Predict Resistance To Vectibix, FOLFOX Combination Treatment

This article is from The Cancer Letter archive.

Vol. 36 No. 9 | September 27, 2013

Download PDF Visit The Full Archive

Related Articles

DePinho’s Handling Of MD Anderson Tenure Dispute Triggers Formal Investigation by AAUP

July 18, 2014

FDA Approves Two PSA Tests By roche; Onconase Gets EU Orphan Designation.

March 2, 2001

Trials Approved In October

December 28, 2001

ASCO Calls On NCI To Double Funding For Cooperative Group Clinical Trials

December 31, 2010

Brachytherapy Better Than Surgery For Prostate Cancer

October 29, 2004

Biotech Firm Plans Custom Clinical trials In USSR for Drug Firms

August 18, 1989